Article
Challenges and Prospects of Patient-Derived Xenografts for Cancer Research
31 Aug 2023
Abstract excerpt
We discuss the importance of the in vivo models in elucidating cancer biology, focusing on the patient-derived xenograft (PDX) models, which are classic and standard functional in vivo platforms for preclinical evaluation. We provide an overview of the most representative models, including cell-derived xenografts (CDX), tumor and metastatic cell-derived xenografts, and PDX models utilizing humanized mice (HM)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
